These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2640068

  • 1. [Conservative treatment of ascites in patients with cirrhosis of the liver].
    Hartleb J, Mazur W.
    Wiad Lek; ; 42(16-18):1000-5. PubMed ID: 2640068
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A, Codden T, Henry JP, Van Cauter J, Meunier JC, Ligny G.
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of ascites in hepatic cirrhosis].
    Arroyo JL, Bueno J, Rivero A, Lucas I, Ortiz de Landazuri E.
    Rev Esp Enferm Apar Dig; 1966 Nov; 25(9):1021-46. PubMed ID: 5997895
    [No Abstract] [Full Text] [Related]

  • 5. [Pathogenesis and treatment of ascites in liver cirrhosis].
    Mansurov KhKh.
    Klin Med (Mosk); 1981 Jan; 59(1):12-5. PubMed ID: 7017257
    [No Abstract] [Full Text] [Related]

  • 6. [Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
    Coltorti M, Radaeli E, Ciaccio S, Corsini R, Trebbi R.
    Clin Ter; 1976 Feb 15; 76(3):215-34. PubMed ID: 963962
    [No Abstract] [Full Text] [Related]

  • 7. [Hyperaldosteronism, spironolactone and liver cirrhosis].
    Sort P, Guevara M, Arroyo V.
    Gastroenterol Hepatol; 1997 Mar 15; 20(3):151-9. PubMed ID: 9162537
    [No Abstract] [Full Text] [Related]

  • 8. Ascites formation and dynamics in cirrhotic patients.
    Gentilini P.
    Eur J Gastroenterol Hepatol; 1995 Aug 15; 7(8):749-51. PubMed ID: 7496863
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Regulation of water-electrolyte balance in cirrhosis of the liver].
    Winnicki C.
    Pol Tyg Lek; 1995 Aug 15; 45(16-18):361-4. PubMed ID: 2146600
    [No Abstract] [Full Text] [Related]

  • 11. [Controlled clinical study of the effect of combined administration of ethacrynic acid and spironolactone in ascitic liver cirrhosis].
    Marra N, Micheli E, Spagnolo G.
    Clin Ter; 1979 Jul 31; 90(2):143-63. PubMed ID: 527296
    [No Abstract] [Full Text] [Related]

  • 12. The impact of diuretics on chronic liver disease.
    Steigmann F, Mejicano R.
    Am J Gastroenterol; 1969 Jul 31; 52(1):37-44. PubMed ID: 5796683
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of resistant ascites in cirrhotic patients].
    Aronoff A, Nayarai I.
    Union Med Can; 1974 Dec 31; 103(12):2081-9. PubMed ID: 4466021
    [No Abstract] [Full Text] [Related]

  • 14. [Intractractable ascites in alcoholic cirrhosis: treatmemt by punctures and reinjections of ascitic fluid associated with diuretics].
    Perrin D, Bredoux P, Arzul C, Bergerault P, Dedieu P, Miniconi P.
    Arch Fr Mal App Dig; 1974 Dec 31; 63(5):365-73. PubMed ID: 4463921
    [No Abstract] [Full Text] [Related]

  • 15. [Therapeutic possibilities and risks in hepatic cirrhosis with water-electrolyte metabolism disorders].
    Schwartz M, Fodor O.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975 Dec 31; 27(3):219-25. PubMed ID: 770
    [No Abstract] [Full Text] [Related]

  • 16. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
    Fuller RK, Khambatta PB, Gobezie GC.
    JAMA; 1977 Mar 07; 237(10):972-5. PubMed ID: 319263
    [Abstract] [Full Text] [Related]

  • 17. Refractory ascites: definition and mechanism.
    Arroyo V, Badalamenti S, Ginès P.
    Minerva Med; 1987 May 31; 78(10):675-80. PubMed ID: 3587714
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of six treatments of ascites in patients with liver cirrhosis. A clinical trial.
    Descos L, Gauthier A, Levy VG, Michel H, Quinton A, Rueff B, Fermanian J, Fombonne E, Durbec JP.
    Hepatogastroenterology; 1983 Feb 31; 30(1):15-20. PubMed ID: 6339343
    [Abstract] [Full Text] [Related]

  • 19. [Letter: Ascrtogenicliver cirrhosis. Effect of amiloride on water-electrolytemetabolsim].
    Bianchi Porre G, Lazzaroni M, Petrillo M.
    Nouv Presse Med; 1975 Apr 05; 4(14):1043. PubMed ID: 1093119
    [No Abstract] [Full Text] [Related]

  • 20. [The salidiuretic interaction of angiotensin II and furosemide in ascitogenic hepatic cirrhosis].
    Ventura E, Zeneroli ML.
    Folia Endocrinol; 1969 Dec 05; 22(4):345-53. PubMed ID: 4329093
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.